In this issue of Cancer Cell, Jeselsohn et al. dissect the function of several of the most clinically important estrogen receptor alpha mutants associated with endocrine therapy resistance in breast cancer and demonstrate that they manifest disease-relevant neomorphic activities that likely contribute to tumor pathogenesis.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.ccell.2018.01.014 | DOI Listing |
Publication Analysis
Top Keywords
breast cancer
8
neomorphic erα
4
erα mutations
4
mutations drive
4
drive progression
4
progression breast
4
cancer challenge
4
challenge drug
4
drug discovery
4
discovery issue
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!